Anti-dengue vaccine dengvaxia for NEET/AIIMS/USMLE/FMGE/PLAB
Dengvaxia: A recent vaccine for dengue approved by FDA.
Learn about the structure of dengvaxia and its indication in detail in this video.
Structure: It has been synthesized on the back bone of 17-D yellow fever vaccine, where antigens of the four dengue viruses have been incorporated.
Route: Subcutaneous
Indication: Age group 9-16 years who had previous one attack of dengue.
AIM: To prevent dengue hemorrhagic fever or dengue shock syndrome which is commonly seen in second infection.
